SCHEMBL4595357

SCHEMBL4595357

Nc1ncc(CCC(=O)Nc2cccc(F)c2)s1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
POLB P06746 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.43
ESR1 P03372 1/20 0.43
ESRRG P62508 1/20 0.43
ESR2 Q92731 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
AURKA O14965 1/20 0.43
AURKB Q96GD4 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
TSHR P16473 1/20 0.43
CDK8 P49336 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL707268 0.88 KMT2A (0.55) SMN1; SMN2KMT2AMEN1POLBPKM
SCHEMBL4594960 0.85 HDAC1 (0.46) SMN1; SMN2POLBALDH1A1GAAHDAC1
SCHEMBL4595127 0.75 GAA (0.51) SMN1; SMN2KMT2AMEN1ALDH1A1PKM
SCHEMBL5027766 0.75 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AMEN1POLBHDAC1
SCHEMBL5025349 0.73 L3MBTL1 (0.55) KMT2AMEN1ALDH1A1GAAMAPT
SCHEMBL2876978 0.73 AURKA (0.60) SMN1; SMN2KMT2AMEN1POLBMAPT
SCHEMBL5025177 0.72 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AMEN1POLBESR1
SCHEMBL5025176 0.72 ALDH1A1 (0.48) SMN1; SMN2KMT2AMEN1ALDH1A1MAPT
SCHEMBL5041435 0.71 AURKA (0.53) SMN1; SMN2KMT2AMEN1ALDH1A1PKM
SCHEMBL8088822 0.70 MEN1 (0.72) SMN1; SMN2KMT2AMEN1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948651-A1 THIAZOLE ANALOGUES AND USES THEREOF 4SC AG (DE) 2008-07-30 EP disclosed
US-20070149523-A1 Thiazole Analogues and Uses Thereof 4SC AG (DE) 2007-06-28 US disclosed
WO-2007054357-A1 THIAZOLE ANALOGUES AND USES THEREOF 4SC AG (DE) 2007-05-18 WO disclosed
EP-1785420-A1 Thiazole analogues and uses thereof 4SC AG (DE) 2007-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149523-A1 Thiazole Analogues and Uses Thereof NR3C2, SLC26A4, CLIC4 SMN1; SMN2 2623/4885KMT2A 2926/4885MEN1 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.